Fortune December 6, 2019
Sy Mukherjee

CVS is celebrating a big milestone this week: The one-year anniversary of the mammoth $69 billion CVS-Aetna deal’s close. And Larry Merlo, CEO of the combined company, has plenty to say on how the integration of a retail pharmacy giant and a major health insurer has gone so far—and what the future holds for CVS following the transformative acquisition.

Fortune sat down with Merlo for a wide-ranging conversation on meeting patients where they are, the value of Aetna to CVS’ expansion ambitions, and the pilot projects the company has coming down the pike.

The top line takeaway? “The Aetna integration certainly has changed CVS into a full-fledged health care company,” says Merlo.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Market Research, Mergers & Acquisitions / JV, Payer, Pharma, Provider, Retail care, Trends
ASHP to CMS: 'Change course' on drug pricing
Many independent pharmacists will not stock drugs in the price negotiation program
Measuring Progress for Life Sciences: Trust, Patient Access, and Prevention at a Fork in the Road of Public Health
2025 Pharma Forecast: Four Pivotal Trends Revolutionizing Market Access Strategies
Christophe Weber, veteran Takeda CEO, to retire next year

Share This Article